SAGE meeting of 5 - 7 April 2011
Background documents
Yellow book
Report from IVB Director including status of implementation of recommendations
-
Meeting of the Strategic Advisory Group of Experts On Immunization, November 2010- Summary, Conclusions and Recommendations
pdf, 411kb -
SAGE tracking record of recommendations and action points
pdf, 117kb -
WHO- GIVS: Progress report and strategic direction for the 'Decade of Vaccines'
pdf, 282kb -
Technical Note: MenAfriVacTM Vaccine Campaigns in the African meningitis belt: Use of vaccine in pregnant and lactating women, 22 November 2010
pdf, 126kb -
WHO-UNICEF. Draft of Delivering Immunization in the Next Decade (V14-01-2011)
pdf, 1.25Mb -
Decade of vaccines - draft
pdf, 19kb -
Summary of Immunization Weeks 2011
pdf, 35kb
Regional priorities, major policy and implementation issues: reports from AFR, EMR and SEAR
AFR
-
WHO, 2nd African Regional Conference on Immunization (ARCI), Ouagadougou, Burkina Faso, 06-08 December 2010
pdf, 69kb -
WHO. Final report of 2nd African regional conference on immunization (ARCI). Ouagadougou, Burkina Faso. 06-08 December 2010
pdf, 956kb
Report from GAVI secretariat
Report from Advisory Committees in Immunization
GACVS
-
Global Advisory Committee on Vaccine Safety (GACVS) report: Weekly epidemiological record. No. 5, 2011, 86, 37–44
pdf, 247kb -
GACVS. Statement on Fluzone and febrile seizures. 24 January 2011
pdf, 30kb -
GACVS. Statement on narcolepsy and vaccination. 8 February 2011
pdf, 37kb
Pandemic and Seasonal influenza vaccines
-
Preview Report (draft) of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza A (H1N1) 2009, 7 March 2011
pdf, 709kb -
WHO draft of 2nd Meeting of the SAGE working group on influenza vaccines and Immunization. 14-15 February 2011. Geneva
pdf, 1.10Mb -
WHO Open-ended working group of member states on pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Executive summary. Technical studies under resolution WHA63.1
pdf, 44kb
Tick-borne encephalitis
-
WHO Draft position paper: Vaccines against Tick-borne-encephalitis
pdf, 659kb -
Grading table of scientific evidence: Table I immunogenicity/protective immunity, with key references
pdf, 311kb -
Grading table of scientific evidence: Table II safety, with key references
pdf, 120kb -
Grading table of scientific evidence: Table III cross protection between serotypes, with key references
pdf, 98kb -
Draft grading table of scientific evidence: Table IV duration of protection, with key references
pdf, 173kb -
Background paper on vaccine and vaccination against Tick-borne encephalitis
pdf, 5.22Mb
Meningococcal meningitis vaccine
-
Background paper on Meningococcal Vaccines
pdf, 2.44Mb -
Serogroup B meningococcal vaccines-an unfinished story. Manish Sadarangani, Andrew Pollard (2010). Lancet Infect Dis.10:112-24. (Reproduced with permission)
pdf, 775kb -
Weekly epidemiological record. 4 October 2002, 77th YEAR. No. 40, 2002, 77, 329-340
pdf, 127kb -
Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand. Helen Campbell et al. (2010).Clin Infect Dis. 15;49(4):597-605. (Reproduced with permission)
pdf, 461kb -
Meningococcal carriage in the African meningitis belt. Lancet Infect Dis. 7:797-803. Caroline L. Trotter, Brian m. Greenwood (2007). (Reproduced with permission)
pdf, 460kb -
Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso. Clinical Infec Dis. 15;49(10):1520-5. Anais Colombini et al. (2009). (Reproduced with permission)
pdf, 385kb
Rubella vaccination
-
WHO draft report of Proceedings of the SAGE Working Group on Rubella. March 17, 2011
pdf, 1.34Mb -
MMWR article on "Progress Toward Control of Rubella and Prevention of Congenital Rubella Syndrome — Worldwide, 2009
pdf, 246kb -
2000 WHO position paper on rubella vaccines
pdf, 178kb
Polio eradication
-
Report of first meeting of the GPEI Independent Monitoring Board. 21-22 December 2010. Geneva
pdf, 83kb - WHO. 64TH World Health Assembly. Eradication of poliomyelitis in Draft progress reports. Report by the Secretariat. A64/26. March 2011 [pdf 171kb]
-
The Global Polio Eradication Initiative (GPEI). Monthly situation report. February 2011
pdf, 100kb -
Polio pipeline 7
pdf, 183kb -
Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria. Jenkins HE et al. N Engl J Med 2010;362:2360-9
pdf, 613kb -
Fractional Doses of Inactivated Poliovirus Vaccine in Oman. Mohammed AJ et al. N Engl J Med 2010;362:2351-9
pdf, 320kb -
Immunogenicity of bivalent type 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Sutter R et al. Lancet 2010;376:1682-88
pdf, 306kb -
Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle-free Device in Cuba. Resik S et al. The Journal of Infectious Diseases 2010: 201(9):1344-1352
pdf, 634kb -
The Economic analysis of the global polio eradication initiative. Tebbens RD et al. Vaccine 2010, doi:10.1016/j.vaccine.2010.10.25
pdf, 407kb
Update on evidence-based review process and GRADing of quality of scientific evidence
Cholera vaccine - feed-back on implementation of SAGE recommendations
-
WHO. Weekly epidemiological record. Cholera vaccines: conclusions and recommendations for SAGE meeting of October 2009 of SAGE. 11 December 2010
pdf, 47kb -
WHO - (2010) Weekly epidemiological record: Cholera vaccines: WHO position paper No 13(85):117-128
pdf, 283kb
Please note that the document entitled "IVI, 2010. An investment case for the accelerated introduction of oral Cholera vaccines + Appendices" has not been made publicly available due to its confidential content.